neutral
Recently
Sanara Medtech exceeds Q4 estimates on revenue growth
Sanara Medtech beat Q4 earnings and revenue estimates, with investor response expected after US markets reopen from the holiday break.
Sanara Medtech reported stronger-than-expected fourth-quarter results, posting an EPS loss of 0.23 compared with the estimated loss of 0.485. Revenue reached $25.83 million, exceeding forecasts by roughly 2.7%. The wound care specialist benefited from higher product adoption during the quarter, with results released amid limited market activity due to the US Christmas holiday.